OliX Pharmaceuticals, Inc (KOSDAQ:226950)

South Korea · Delayed Price · Currency is KRW

111,600

-2,600 (-2.28%)

Sep 18, 2026, 3:30 PM KST

OliX Pharmaceuticals Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	13,636	14,667	5,677	17,064	9,320	3,674
Revenue Growth	80.93%	158.35%	-66.73%	83.09%	153.66%	48.50%
Gross Profit	13,303	14,334	5,428	16,904	9,113	3,503
Operating Income	-41,552	-29,972	-30,919	-18,185	-22,376	-24,229
Net Income	-14,030	-15,743	-40,659	-19,102	-19,495	-29,715
Earnings Per Share	-662.79	-800.46	-2414.00	-1324.00	-1422.69	-2171.18
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	214,149	132,513	12,414	25,925	61,872	49,757
Total Debt	20,819	23,287	39,192	39,357	43,996	37,271
Net Cash (Debt)	193,329	109,227	-26,778	-13,433	17,876	12,487
Net Cash Growth	-	-	-	-	43.16%	-76.70%
Net Cash Per Share	9132.85	5553.79	-1589.86	-930.93	1304.50	912.36

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-30,082	-15,900	-28,045	-21,168	-30,683	-19,054
Capital Expenditures	-1,464	-1,262	-13,465	-8,826	-2,233	-1,290
Free Cash Flow	-31,547	-17,161	-41,510	-29,995	-32,916	-20,344
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	97.56%	97.73%	95.62%	99.06%	97.78%	95.33%
Operating Margin	-304.72%	-204.36%	-544.62%	-106.57%	-240.07%	-659.40%
Pretax Margin	-101.95%	-90.35%	-723.44%	-106.48%	-312.30%	-816.40%
Profit Margin	-102.89%	-107.34%	-716.18%	-111.94%	-209.17%	-808.70%
FCF Margin	-231.35%	-117.01%	-731.17%	-175.77%	-353.16%	-553.66%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	186.20	193.27	62.63	13.69	29.92	152.91